308 related articles for article (PubMed ID: 25538220)
1. USP45 deubiquitylase controls ERCC1-XPF endonuclease-mediated DNA damage responses.
Perez-Oliva AB; Lachaud C; Szyniarowski P; Muñoz I; Macartney T; Hickson I; Rouse J; Alessi DR
EMBO J; 2015 Feb; 34(3):326-43. PubMed ID: 25538220
[TBL] [Abstract][Full Text] [Related]
2. The structure-specific endonuclease Ercc1-Xpf is required to resolve DNA interstrand cross-link-induced double-strand breaks.
Niedernhofer LJ; Odijk H; Budzowska M; van Drunen E; Maas A; Theil AF; de Wit J; Jaspers NG; Beverloo HB; Hoeijmakers JH; Kanaar R
Mol Cell Biol; 2004 Jul; 24(13):5776-87. PubMed ID: 15199134
[TBL] [Abstract][Full Text] [Related]
3. The XPA-binding domain of ERCC1 is required for nucleotide excision repair but not other DNA repair pathways.
Orelli B; McClendon TB; Tsodikov OV; Ellenberger T; Niedernhofer LJ; Schärer OD
J Biol Chem; 2010 Feb; 285(6):3705-3712. PubMed ID: 19940136
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of the ERCC1-XPF structure-specific endonuclease to overcome cancer chemoresistance.
McNeil EM; Astell KR; Ritchie AM; Shave S; Houston DR; Bakrania P; Jones HM; Khurana P; Wallace C; Chapman T; Wear MA; Walkinshaw MD; Saxty B; Melton DW
DNA Repair (Amst); 2015 Jul; 31():19-28. PubMed ID: 25956741
[TBL] [Abstract][Full Text] [Related]
5. Acetylation of XPF by TIP60 facilitates XPF-ERCC1 complex assembly and activation.
Wang J; He H; Chen B; Jiang G; Cao L; Jiang H; Zhang G; Chen J; Huang J; Yang B; Zhou C; Liu T
Nat Commun; 2020 Feb; 11(1):786. PubMed ID: 32034146
[TBL] [Abstract][Full Text] [Related]
6. XPF knockout via CRISPR/Cas9 reveals that ERCC1 is retained in the cytoplasm without its heterodimer partner XPF.
Lehmann J; Seebode C; Smolorz S; Schubert S; Emmert S
Cell Mol Life Sci; 2017 Jun; 74(11):2081-2094. PubMed ID: 28130555
[TBL] [Abstract][Full Text] [Related]
7. ERCC1-XPF endonuclease facilitates DNA double-strand break repair.
Ahmad A; Robinson AR; Duensing A; van Drunen E; Beverloo HB; Weisberg DB; Hasty P; Hoeijmakers JH; Niedernhofer LJ
Mol Cell Biol; 2008 Aug; 28(16):5082-92. PubMed ID: 18541667
[TBL] [Abstract][Full Text] [Related]
8. Mislocalization of XPF-ERCC1 nuclease contributes to reduced DNA repair in XP-F patients.
Ahmad A; Enzlin JH; Bhagwat NR; Wijgers N; Raams A; Appledoorn E; Theil AF; J Hoeijmakers JH; Vermeulen W; J Jaspers NG; Schärer OD; Niedernhofer LJ
PLoS Genet; 2010 Mar; 6(3):e1000871. PubMed ID: 20221251
[TBL] [Abstract][Full Text] [Related]
9. Removal of reactive oxygen species-induced 3'-blocked ends by XPF-ERCC1.
Fisher LA; Samson L; Bessho T
Chem Res Toxicol; 2011 Nov; 24(11):1876-81. PubMed ID: 22007867
[TBL] [Abstract][Full Text] [Related]
10. The formation of UV-induced chromosome aberrations involves ERCC1 and XPF but not other nucleotide excision repair genes.
Chipchase MD; Melton DW
DNA Repair (Amst); 2002 Apr; 1(4):335-40. PubMed ID: 12509251
[TBL] [Abstract][Full Text] [Related]
11. Physiological consequences of defects in ERCC1-XPF DNA repair endonuclease.
Gregg SQ; Robinson AR; Niedernhofer LJ
DNA Repair (Amst); 2011 Jul; 10(7):781-91. PubMed ID: 21612988
[TBL] [Abstract][Full Text] [Related]
12. Functional and physical interactions between ERCC1 and MSH2 complexes for resistance to cis-diamminedichloroplatinum(II) in mammalian cells.
Lan L; Hayashi T; Rabeya RM; Nakajima S; Kanno Si; Takao M; Matsunaga T; Yoshino M; Ichikawa M; Riele Ht; Tsuchiya S; Tanaka K; Yasui A
DNA Repair (Amst); 2004 Feb; 3(2):135-43. PubMed ID: 14706347
[TBL] [Abstract][Full Text] [Related]
13. Targeting the DNA Repair Endonuclease ERCC1-XPF with Green Tea Polyphenol Epigallocatechin-3-Gallate (EGCG) and Its Prodrug to Enhance Cisplatin Efficacy in Human Cancer Cells.
Heyza JR; Arora S; Zhang H; Conner KL; Lei W; Floyd AM; Deshmukh RR; Sarver J; Trabbic CJ; Erhardt P; Chan TH; Dou QP; Patrick SM
Nutrients; 2018 Nov; 10(11):. PubMed ID: 30400270
[TBL] [Abstract][Full Text] [Related]
14. Function and Interactions of ERCC1-XPF in DNA Damage Response.
Faridounnia M; Folkers GE; Boelens R
Molecules; 2018 Dec; 23(12):. PubMed ID: 30563071
[TBL] [Abstract][Full Text] [Related]
15. Mapping of interaction domains between human repair proteins ERCC1 and XPF.
de Laat WL; Sijbers AM; Odijk H; Jaspers NG; Hoeijmakers JH
Nucleic Acids Res; 1998 Sep; 26(18):4146-52. PubMed ID: 9722633
[TBL] [Abstract][Full Text] [Related]
16. Characterisation of Ercc1 deficiency in the liver and in conditional Ercc1-deficient primary hepatocytes in vitro.
Kirschner K; Singh R; Prost S; Melton DW
DNA Repair (Amst); 2007 Mar; 6(3):304-16. PubMed ID: 17126084
[TBL] [Abstract][Full Text] [Related]
17. Domain mapping of the DNA binding, endonuclease, and ERCC1 binding properties of the human DNA repair protein XPF.
McCutchen-Maloney SL; Giannecchini CA; Hwang MH; Thelen MP
Biochemistry; 1999 Jul; 38(29):9417-25. PubMed ID: 10413517
[TBL] [Abstract][Full Text] [Related]
18. Action of DNA repair endonuclease ERCC1/XPF in living cells.
Houtsmuller AB; Rademakers S; Nigg AL; Hoogstraten D; Hoeijmakers JH; Vermeulen W
Science; 1999 May; 284(5416):958-61. PubMed ID: 10320375
[TBL] [Abstract][Full Text] [Related]
19. The ERCC1 and ERCC4 (XPF) genes and gene products.
Manandhar M; Boulware KS; Wood RD
Gene; 2015 Sep; 569(2):153-61. PubMed ID: 26074087
[TBL] [Abstract][Full Text] [Related]
20. Defects in interstrand cross-link uncoupling do not account for the extreme sensitivity of ERCC1 and XPF cells to cisplatin.
De Silva IU; McHugh PJ; Clingen PH; Hartley JA
Nucleic Acids Res; 2002 Sep; 30(17):3848-56. PubMed ID: 12202770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
